MorphoSys AG (NASDAQ: MOR) reported Q2 EPS of (EUR3.50), EUR2.92 worse than the analyst estimate of (EUR0.58). Revenue for the quarter came in at EUR63.8 million versus the consensus estimate of EUR61.68 million.

For earnings history and earnings-related data on MorphoSys AG (MOR) click here.